Gainers
- Aesthetic Medical Intl AIH shares rose 14.0% to $0.52 during Wednesday's after-market session. The company's market cap stands at $24.9 million.
- Kineta KA shares rose 8.46% to $0.58. The company's market cap stands at $6.3 million.
- Simulations Plus SLP shares increased by 6.74% to $40.99. The market value of their outstanding shares is at $818.4 million. As per the news, the Q2 earnings report came out today.
- Bolt Biotherapeutics BOLT shares moved upwards by 6.66% to $1.44. The company's market cap stands at $54.9 million.
- Eiger BioPharmaceuticals EIGR shares increased by 6.66% to $1.76. The market value of their outstanding shares is at $2.6 million.
- Kodiak Sciences KOD shares rose 5.38% to $4.5. The company's market cap stands at $236.2 million. As per the news, the Q4 earnings report came out 4 days ago.
Losers
- Connect Biopharma Hldgs CNTB shares fell 10.8% to $1.9 during Wednesday's after-market session. The company's market cap stands at $104.6 million.
- Acorda Therapeutics ACOR stock fell 10.4% to $1.81. The market value of their outstanding shares is at $2.2 million. As per the news, the Q4 earnings report came out 2 days ago.
- Innate Pharma IPHA shares decreased by 8.54% to $2.25. The market value of their outstanding shares is at $181.8 million.
- Qilian Intl Hldg Gr QLI shares declined by 8.51% to $0.64. The market value of their outstanding shares is at $22.8 million.
- Universe Pharmaceuticals UPC shares fell 7.33% to $2.53. The company's market cap stands at $9.2 million.
- Helius Medical Tech HSDT shares declined by 6.33% to $6.07. The company's market cap stands at $5.3 million. As per the press release, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in